SUVRETTA CAPITAL MANAGEMENT, LLC
Q3 2022 13F-HR Holdings
Net value change ($000)
-221,593
(-8.4%)
New positions
12
Sold out positions
28
Turnover %
35.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AMZN | 82,881 | NEW |
| META | 67,608 | NEW |
| TTWO | 58,443 | NEW |
| DIS | 54,303 | 163.9% |
| NOW | 46,073 | 379.6% |
| GPN | 39,426 | 124.1% |
| TMUS | 39,072 | 370.4% |
| PROK | 28,771 | NEW |
| HLT | 25,586 | 63.7% |
| MSFT | 24,808 | 38.6% |
Top Reduces (Value $000, Stocks/ETFs)
| HUM | -92,522 | -100.0% |
| CNC | -68,317 | -100.0% |
| Mirati Therapeutics, Inc. | -63,907 | -100.0% |
| RPRX | -55,380 | -42.8% |
| VTRS | -40,643 | -100.0% |
| FIS | -40,632 | -100.0% |
| Intra-Cellular Therapies, Inc. | -36,771 | -48.1% |
| RH | -28,300 | -100.0% |
| MQ | -28,091 | -100.0% |
| XOM | -24,898 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
33,393
(1.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|